2026年全球虛擬活體組織切片市場報告

近年來，虛擬切片檢查市場發展迅速，預計將從2025年的7.1億美元成長到2026年的7.9億美元，複合年成長率達11.9%。過去幾年成長要素包括對傳統切片檢查程序的依賴、影像診斷技術的局限性、慢性病患病率的上升、醫院和診斷基礎設施的擴建以及對精準癌症診斷日益成長的需求。

預計未來幾年虛擬切片檢查市場規模將快速成長，到2030年將達到12.3億美元，複合年成長率（CAGR）為11.7%。預測期內的成長可歸因於影像演算法和人工智慧分析技術的進步、腫瘤學和神經系統疾病診斷應用的擴展、心血管和眼科疾病領域應用的增加、與個人化醫療方法的融合，以及對研究機構和診斷中心投資的增加。預測期內的主要趨勢包括：非侵入性診斷程序的普及、對疾病早期檢測需求的成長、先進成像和預測分析技術的融合、虛擬切片檢查在多個治療領域的應用擴展，以及對患者舒適度和縮短康復時間的日益重視。

癌症發生率的上升預計將在未來幾年推動虛擬切片檢查市場的成長。癌症是指由體內細胞異常增生和擴散引起的與癌症相關的健康問題。這些疾病發生率的上升主要歸因於生活方式因素，例如不合理的飲食、缺乏運動、吸煙以及環境污染暴露的增加。虛擬切片檢查透過提供非侵入性的即時影像診斷訊息，改善了腫瘤疾病的診斷和後續觀察。這可以提高診斷準確性和病人安全性，同時減少對傳統組織切片檢查的依賴。例如，根據美國數位健康研究公司Rock Health於2023年1月發布的報告，預計2023年美國新增癌症病例將達到1,958,310例，高於2022年的約190萬例。因此，腫瘤發生率的上升正在推動虛擬切片檢查市場的成長。

遠距遠端醫療需求的不斷成長預計也將推動虛擬切片檢查市場的發展。遠端醫療是指利用視訊會議、行動應用程式和通訊網路等數位通訊技術遠端提供醫療服務。遠端醫療的日益普及得益於醫療服務可近性的提高、成本效益的提升以及數位健康技術的進步。虛擬切片檢查透過先進的影像技術和基於人工智慧的分析，實現遠端、非侵入性的組織評估，從而支援遠距遠端醫療。這使得臨床醫生無需面對面會診即可後續觀察和診斷患者，有助於提高醫療服務的可近性和連續性。例如，美國數據管理公司Harmony Healthcare IT於2023年7月發布的一項調查顯示，62%的美國人將使用遠端醫療服務來滿足其醫療需求，超過77%的人認為遠距醫療是醫療保健的未來發展方向。因此，對遠端醫療需求的不斷成長正在推動虛擬切片檢查市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球虛擬活體組織切片市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 身臨其境型技術（AR/VR/XR）與數位體驗
• 主要趨勢
  • 非侵入性診斷程序的採用率不斷提高
  • 對疾病早期檢測的需求日益成長
  • 整合先進的影像技術和預測分析技術
  • 將虛擬切片檢查的應用擴展到多個治療領域
  • 更加重視提高患者舒適度並縮短復原時間

第5章 終端用戶產業市場分析

• 醫院和診所
• 研究機構和診斷中心
• 腫瘤中心
• 神經科診所
• 其他專業診斷機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球虛擬活體組織切片市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球虛擬活體組織切片市場規模、對比及成長率分析
• 全球虛擬活體組織切片市場表現：規模與成長，2020-2025年
• 全球虛擬活體組織切片市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

• 按治療領域
• 腫瘤、神經系統疾病、心血管疾病、眼科疾病、內分泌疾病及胃腸道疾病等目標治療領域
• 按癌症類型
• 固態惡性腫瘤、乳癌、肺癌、攝護腺癌、大腸直腸癌、腦腫瘤及其他癌症標靶區
• 透過影像診斷技術
• 磁振造影、電腦斷層掃描、X光、超音波和其他診斷影像技術
• 最終用戶
• 醫院/診所、實驗室/診斷中心及其他最終用戶
• 按類型細分：腫瘤疾病
• 肺癌、乳癌、攝護腺癌、結腸癌、肝癌、腦瘤和其他癌症
• 按類型細分：神經系統疾病
• 阿茲海默症、巴金森氏症、多發性硬化症、癲癇、腦損傷、中風和其他神經系統疾病
• 按類型細分：循環系統疾病
• 冠狀動脈疾病、心臟衰竭、心律不整、主動脈瘤、瓣膜性心臟病、心肌梗塞和其他心血管疾病
• 按類型細分：眼科疾病
• 老齡化黃斑部病變、糖尿病視網膜病變、青光眼、視網膜靜脈阻塞、白內障
• 按類型細分：內分泌疾病
• 糖尿病、甲狀腺疾病、腎上腺疾病、腦下垂體疾病、副甲狀腺疾病和其他內分泌疾病
• 按類型細分：胃腸道疾病
• 發炎性腸道疾病、結腸息肉、胃潰瘍、肝硬化、胰臟疾病、肝炎和其他消化系統疾病
• 按類型細分：其他標靶治療領域
• 肌肉骨骼疾病、腎臟疾病、呼吸系統疾病、血液疾病、皮膚疾病、感染疾病及其他疾病

第10章 區域與國家分析

• 全球虛擬活體組織切片市場：按地區、業績和預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球虛擬活體組織切片市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 虛擬活體組織切片市場：競爭格局和市場佔有率（2024 年）
• 虛擬活體組織切片市場：公司估值矩陣
• 虛擬活體組織切片市場：公司概況
  • Siemens Healthineers AG
  • GE Healthcare
  • Canon Medical Systems
  • Philips Healthcare
  • Fujifilm Healthcare

第37章：其他領先和創新企業

• Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年虛擬活體組織切片市場：提供新機會的國家
• 2030年虛擬活體組織切片市場：蘊藏新機會的細分領域
• 2030年虛擬活體組織切片市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Virtual biopsy is a non-invasive diagnostic method that leverages advanced imaging technologies and computer algorithms to analyze tissues for signs of disease. Its primary goal is to identify abnormalities, such as tumors or infections, without the need for traditional tissue sampling, minimizing risks and recovery time for patients. This technique is safer, faster, and less painful compared to conventional biopsies.

The main therapeutic areas targeted by virtual biopsy include oncology, neurology, cardiology, ophthalmology, endocrinology, gastroenterology, and other related conditions. Oncological disorders involve diseases characterized by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy is used for detecting a wide range of cancers, including solid tumors, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies utilized in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, among others, and are employed by end users such as hospitals, clinics, research institutes, diagnostic centers, and more.

Tariffs are impacting the virtual biopsy market by increasing the cost of importing advanced imaging equipment, software platforms, and diagnostic tools. Segments such as magnetic resonance imaging and computed tomography devices are most impacted, particularly in Asia-Pacific regions including China and India. While tariffs have raised production and operational costs, they also encourage local manufacturing, foster innovation in cost-effective imaging solutions, and promote the development of domestic diagnostic technology capabilities.

The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides virtual biopsy market statistics, including virtual biopsy industry global market size, regional shares, competitors with a virtual biopsy market share, detailed virtual biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy industry. This virtual biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.71 billion in 2025 to $0.79 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to reliance on traditional biopsy procedures, limited imaging technology capabilities, increasing prevalence of chronic diseases, growing hospital and diagnostic infrastructure, rising demand for accurate cancer diagnostics.

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.23 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to advancements in imaging algorithms and ai analytics, expansion of oncology and neurological diagnostic applications, increasing adoption in cardiovascular and ophthalmological disorders, integration with personalized medicine approaches, rising investment in research institutes and diagnostic centers. Major trends in the forecast period include increased adoption of non-invasive diagnostic procedures, rising demand for early disease detection, integration of advanced imaging with predictive analytics, expansion of virtual biopsy applications across multiple therapeutic areas, growing focus on patient comfort and reduced recovery time.

The rising prevalence of oncological disorders is expected to drive the growth of the virtual biopsy market in the coming years. Oncological disorders are health conditions related to cancer, characterized by the abnormal growth and spread of cells in the body. The increasing prevalence of these disorders is largely attributed to lifestyle factors such as poor diet, physical inactivity, tobacco use, and greater exposure to environmental pollutants. Virtual biopsy enhances the diagnosis and monitoring of oncological disorders by providing non-invasive, real-time imaging insights, reducing reliance on traditional tissue biopsies while improving accuracy and patient safety. For example, in January 2023, Rock Health, a U.S.-based digital health research firm, reported that 1,958,310 new cancer cases were projected in the U.S. for 2023, up from approximately 1.9 million cases in 2022. Therefore, the rising prevalence of oncological disorders is driving the virtual biopsy market.

The growing demand for telemedicine is also expected to propel the virtual biopsy market. Telemedicine refers to the remote delivery of healthcare services using digital communication technologies, including video conferencing, mobile applications, and telecommunication networks. The increasing adoption of telemedicine is driven by improved healthcare accessibility, cost efficiency, and advancements in digital health technologies. Virtual biopsy supports telemedicine by enabling remote, non-invasive tissue assessment through advanced imaging and AI-powered analysis, allowing clinicians to monitor and diagnose patients without in-person visits, thereby enhancing accessibility and continuity of care. For instance, in July 2023, Harmony Healthcare IT, a US-based data management firm, reported that 62% of Americans had used telehealth services for medical needs, with over three-quarters (77%) viewing it as the future of healthcare. Therefore, the rising demand for telemedicine is driving the growth of the virtual biopsy market.

Major companies in the virtual biopsy market are focusing on developing technologically advanced solutions and obtaining regulatory approvals, such as magnetic resonance spectroscopy (MRS) platforms, to enhance non-invasive diagnostic accuracy and provide real-time analysis for early disease detection and personalized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that enables virtual biopsy by providing detailed molecular information of tissues, allowing accurate, real-time disease detection and monitoring without invasive procedures. For example, in November 2023, BrainSpec Inc., a US-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its AI-driven BrainSpec platform. This technology applies advanced artificial intelligence analysis to MR spectroscopy data to measure brain metabolites such as 2-hydroxyglutarate, facilitating non-invasive virtual biopsies for conditions including gliomas, Alzheimer's disease, and multiple sclerosis. The system integrates seamlessly with standard MRI scanners, automates data processing, delivers results within minutes, and leverages a reference database of brain chemistry to improve diagnostic accuracy.

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the virtual biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses virtual biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virtual biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Target Thrapeutic Areas: Oncological Disorders; Neurological Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Endocrine Disorders; Gastrointestinal Disorders; Other Target Therapeutic Areas
• 2) By Cancer Targeted: Solid Malignancies; Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Cancer; Other Cancer Targeteds
• 3) By Imaging Technologies: Magnetic Resonance Imaging; Computed Tomography; X-Ray; Ultrasound; Other Imaging Technologies
• 4) By End Users: Hospitals And Clinics; Research Institutes And Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Oncological Disorders: Lung Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Liver Cancer; Brain Tumors; Other Cancers
• 2) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Brain Injuries; Stroke; Other Neurological Conditions
• 3) By Cardiovascular Disorders: Coronary Artery Disease; Heart Failure; Arrhythmias; Aortic Aneurysm; Valvular Heart Disease; Myocardial Infarction; Other Cardiovascular Conditions
• 4) By Ophthalmological Disorders: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinal Vein Occlusion; Cataracts; Other Eye Disorders
• 5) By Endocrine Disorders: Diabetes Mellitus; Thyroid Disorders; Adrenal Gland Disorders; Pituitary Gland Disorders; Parathyroid Disorders; Other Endocrine Conditions
• 6) By Gastrointestinal Disorders: Inflammatory Bowel Disease; Colorectal Polyps; Gastric Ulcers; Liver Cirrhosis; Pancreatic Disorders; Hepatitis; Other Gastrointestinal Conditions
• 7) By Other Target Therapeutic Areas: Musculoskeletal Disorders; Renal Disorders; Pulmonary Disorders; Hematologic Disorders; Dermatological Disorders; Infectious Diseases; Other Miscellaneous Conditions
• Companies Mentioned: Siemens Healthineers AG; GE Healthcare; Canon Medical Systems; Philips Healthcare; Fujifilm Healthcare; Esaote SpA; Samsung Medison; Perspectum Ltd; QUIBIM SL; ImageBiopsy Lab GmbH; Deep Bio Inc; BrainSpec Inc; Oncoustics Inc; AI Metrics LLC; Zebra Medical Vision; Arterys Inc; Aidoc Medical; Viz ai; Subtle Medical; Gleamer AI
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Virtual Biopsy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Virtual Biopsy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Virtual Biopsy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Virtual Biopsy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increased Adoption Of Non-Invasive Diagnostic Procedures
  • 4.2.2 Rising Demand For Early Disease Detection
  • 4.2.3 Integration Of Advanced Imaging With Predictive Analytics
  • 4.2.4 Expansion Of Virtual Biopsy Applications Across Multiple Therapeutic Areas
  • 4.2.5 Growing Focus On Patient Comfort And Reduced Recovery Time

5. Virtual Biopsy Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Research Institutes And Diagnostic Centers
• 5.3 Oncology Centers
• 5.4 Neurology Clinics
• 5.5 Other Specialized Diagnostic Facilities

6. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Virtual Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Virtual Biopsy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Virtual Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Virtual Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Virtual Biopsy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Virtual Biopsy Market Segmentation

• 9.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
• 9.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
• 9.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
• 9.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users
• 9.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
• 9.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
• 9.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
• 9.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts
• 9.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
• 9.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
• 9.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

10. Virtual Biopsy Market Regional And Country Analysis

• 10.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Virtual Biopsy Market

• 11.1. Asia-Pacific Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Virtual Biopsy Market

• 12.1. China Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Virtual Biopsy Market

• 13.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Virtual Biopsy Market

• 14.1. Japan Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Virtual Biopsy Market

• 15.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Virtual Biopsy Market

• 16.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Virtual Biopsy Market

• 17.1. South Korea Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Virtual Biopsy Market

• 18.1. Taiwan Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Virtual Biopsy Market

• 19.1. South East Asia Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Virtual Biopsy Market

• 20.1. Western Europe Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Virtual Biopsy Market

• 21.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Virtual Biopsy Market

• 22.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Virtual Biopsy Market

• 23.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Virtual Biopsy Market

• 24.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Virtual Biopsy Market

• 25.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Virtual Biopsy Market

• 26.1. Eastern Europe Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Virtual Biopsy Market

• 27.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Virtual Biopsy Market

• 28.1. North America Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Virtual Biopsy Market

• 29.1. USA Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Virtual Biopsy Market

• 30.1. Canada Virtual Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Virtual Biopsy Market

• 31.1. South America Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Virtual Biopsy Market

• 32.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Virtual Biopsy Market

• 33.1. Middle East Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Virtual Biopsy Market

• 34.1. Africa Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Segmentation By Cancer Targeted, Segmentation By Imaging Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Virtual Biopsy Market Regulatory and Investment Landscape

36. Virtual Biopsy Market Competitive Landscape And Company Profiles

• 36.1. Virtual Biopsy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Virtual Biopsy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Virtual Biopsy Market Company Profiles
  • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Canon Medical Systems Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Fujifilm Healthcare Overview, Products and Services, Strategy and Financial Analysis

37. Virtual Biopsy Market Other Major And Innovative Companies

• Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

38. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Virtual Biopsy Market

40. Virtual Biopsy Market High Potential Countries, Segments and Strategies

• 40.1 Virtual Biopsy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Virtual Biopsy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Virtual Biopsy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer